Guangdong VTR Bio-Tech Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 180.86 million compared to CNY 423.52 million a year ago. Net loss was CNY 13.68 million compared to CNY 31.78 million a year ago.

Basic loss per share from continuing operations was CNY 0.0279 compared to CNY 0.0649 a year ago. Diluted loss per share from continuing operations was CNY 0.0279 compared to CNY 0.0649 a year ago.